It is with great sadness that we mark the passing of Dr. Charles Boucher. As one of the smartest scientists in the HIV field, Charles made major contributions to the areas of HIV virology and drug resistance. He had a passion for addressing scientific challenges to help improve the lives of patients worldwide. We were very fortunate to count him as a colleague and friend in our consortium and shared a common goal to advancing HIV science, delivering innovations to people who need it most, and help bring an end to AIDS. His intellectual contribution, collaborative spirit, and enthusiasm for our mission will leave a tremendous void. Our thoughts are with his family and with his team and colleagues at the Erasmus University. 

 

News

  • EHVA P01: a phase I, prophylactic HIV vaccine trial

    EHVA P01 / ANRS VRI08 is a phase I, prophylactic HIV vaccine trial to evaluate the safety and...

    Read More …

  • EHVA Latest News

    EHVA latest newsletter is available...

    Read More …

  • EHVA Halts Phase II EHVA-T02 Clinical Trial of a Candidate Therapeutic HIV Vaccine and Immunotherapy Drug

    The European HIV Vaccine Alliance (EHVA) has announced that the EHVA T02 / ANRS VRI07 trial, a...

    Read More …

europa  

This project has received funding from the European Union's Horizon 2020 research
and innovation programme under grant agreement N° 681032